Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
University of Pittsburgh Medical Center (UPMC) diabetes research physicians are studying the
action in muscle tissue of "inhaled" insulin (Exubera®) and "infused" (intravenous or IV)
insulin on blood sugar control in people with type 1 diabetes. Type 1 diabetics often take
2-4 shots of insulin every day. Exubera may offer an alternative to these insulin injections.